Lineage Cell Therapeutics

LCTX

Börsenwert 286 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Broadwood Capital New York	89,9 Mio. $	–	–	–
2	2 Vanguard Group Malvern, Pennsylvania	9,9 Mio. $	+363.642 $	+118.427	+4 %
3	3 BlackRock Fund Advisors San Francisco, California	8,11 Mio. $	+1,04 Mio. $	+338.900	+15 %
4	4 BlackRock Institutional Trust San Francisco, California	7,4 Mio. $	+223.420 $	+72.761	+3 %
5	AG 5 Artal Group Luxembourg	4,63 Mio. $	–	–	–
6	6 State Street Boston, Massachusetts	3,78 Mio. $	+313.026 $	+101.943	+9 %
7	7 Northern Trust Chicago, Illinois	2,68 Mio. $	+101.846 $	+33.168	+4 %
8	MHP 8 Manatuck Hill Partners Westport, Connecticut	2,64 Mio. $	-526.454 $	-171.450	-17 %
9	9 Destination Wealth Management Walnut Creek, California	2,13 Mio. $	–	–	–
10	10 Geode Capital Management Boston, Massachusetts	1,45 Mio. $	+58.381 $	+19.013	+4 %
11	11 Bank of New York Mellon New York	1,37 Mio. $	+429.844 $	+139.987	+48 %
12	12 BlackRock Investment Management Wilmington, Delaware	1 Mio. $	+10.124 $	+3.297	+1 %
13	13 Morgan Stanley New York	754.000 $	+661.168 $	+215.322	+923 %
14	14 TIAA CREF Investment Management New York	617.000 $	-69.724 $	-22.707	-10 %
15	15 Veritable Wilmington, Delaware	560.000 $	–	–	–
16	16 California State Teachers Retirement System (CalSTRS) West Sacramento, California	517.000 $	-14.039 $	-4.572	-3 %
17	17 Susquehanna International Group Bala Cynwyd, Pennsylvania	464.000 $	+365.558 $	+119.051	+425 %
18	18 Family Management New York	415.000 $	+98.271 $	+32.004	+32 %
19	19 D.E. Shaw & Co New York	402.000 $	+103.756 $	+33.790	+36 %
20	20 Charles Schwab San Francisco, California	389.000 $	–	–	–
21	21 Teachers Advisors New York	371.000 $	–	–	–
22	22 Swiss National Bank Zurich, Switzerland	336.000 $	–	–	–
23	23 PNC Financial Services Group Pittsburgh, Pennsylvania	290.000 $	–	–	–
24	24 Granite Point Capital Management Boston, Massachusetts	284.000 $	–	–	–
25	25 Jane Street New York	280.000 $	-24.448 $	-7.962	-8 %

Lineage Cell Therapeutics LCTX Börsenwert 286 Mio. $

Lineage Cell Therapeutics

LCTX

Börsenwert 286 Mio. $